Evidence map›Paper›PMID 12070342›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Liquid-liquid separation in solutions of normal and sickle cell hemoglobin.

Oleg Galkin, Kai Chen, Ronald L Nagel, Rhoda Elison Hirsch, Peter G Vekilov

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 203 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mesoscopic protein-rich clusters host the nucleation of mutant p53 amyloid fibrils.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Review
  18. Article
  19. Multivalent ions and biomolecules: Attempting a comprehensive perspective.Chemphyschem : a European journal of chemical physics and physical chemistry · 2020
    Review
  20. ACS nano · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Oleg GalkinDepartment of Chemical Engineering, University of Houston, Houston, TX 77204, USA.
Kai Chen
Ronald L Nagel
Rhoda Elison Hirsch
Peter G Vekilov
Albert Einstein College of Medicine · USUniversity of Alabama · US

Funding

CONTROL OF PROTEIN NUCLEATION AND CRYSTALLITE GROWTHR01HL058038 · NHLBI · UNIVERSITY OF ALABAMA IN HUNTSVILLE · PI VEKILOV, PETER G · 1998 to 2000
$144k
NHLBI NIH HHS R01 HL58038
6 · The paper itself

Abstract

We show that in solutions of human hemoglobin (Hb)--oxy- and deoxy-Hb A or S--of near-physiological pH, ionic strength, and Hb concentration, liquid-liquid phase separation occurs reversibly and reproducibly at temperatures between 35 and 40 degrees C. In solutions of deoxy-HbS, we demonstrate that the dense liquid droplets facilitate the nucleation of HbS polymers, whose formation is the primary pathogenic event for sickle cell anemia. In view of recent results that shifts of the liquid-liquid separation phase boundary can be achieved by nontoxic additives at molar concentrations up to 30 times lower than the protein concentrations, these findings open new avenues for the inhibition of the HbS polymerization.

Indexed as

BuffersHemoglobinsHemoglobin, SickleHot TemperatureHumansHydrogen-Ion ConcentrationMicroscopy, Atomic ForceOsmolar ConcentrationBuffersHemoglobinsHemoglobin, Sickle

Identifiers

PMID12070342
PMCPMC124280
OpenAlexW2022373767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.